C. Hawkey

C. Hawkey, W. Weinstein, D. Richard, 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Drugs and harm to society

C. Hawkey, N. Sheron, I. Gilmore, 2011, The Lancet.

Projections of alcohol deaths—a wake-up call

C. Hawkey, N. Sheron, I. Gilmore, 2011, The Lancet.

Glutathione S-transferase M 1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli 1 – 3

Moira A. Taylor, C. Hawkey, D. Barrett, 2005 .

Phenotypic and functional characterisation of myofibroblasts, macrophages, and lymphocytes migrating out of the human gastric lamina propria following the loss of epithelial cells

T. Gray, C. Hawkey, L. Jackson, 1999, Gut.

Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial

T. Cameron Waller, J. McMurray, P. Jhund, 2020, The Lancet.

Is Stem Cell Therapy Ready for Prime Time in Treatment of Inflammatory Bowel Diseases?

D. Hommes, C. Hawkey, 2017, Gastroenterology.

Assessment of non-steroidal anti-inflammatory drug (NSAID) damage in the human gastrointestinal tract.

C. Hawkey, M. James, 2003, British journal of clinical pharmacology.

Potential alternatives to COX 2 inhibitors

C. Hawkey, M. Skelly, 2002, BMJ : British Medical Journal.

Research priority setting in Barrett's oesophagus and gastro-oesophageal reflux disease.

J. Mclaughlin, S. Hamdy, C. Hawkey, 2017, The lancet. Gastroenterology & hepatology.

Priority Setting in Barrett ’ s Oesophagus and Gastroesophageal Reflux Disease

J. Mclaughlin, S. Hamdy, C. Hawkey, 2017 .

Textbook of Clinical Gastroenterology and Hepatology: Hawkey/Textbook of Clinical Gastroenterology and Hepatology

F. Chan, C. Hawkey, J. Bosch, 2012 .

Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans

C. Hawkey, U. Fagerholm, I. Bjarnason, 2003, Gut.

Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation

G. Lucchini, B. Sharrack, C. Hawkey, 2022, British journal of haematology.

Angiogenesis in gastric ulcers: impaired in patients taking non-steroidal anti-inflammatory drugs.

C. Hawkey, M. Balsitis, N. Hudson, 1995, Gut.

A lay doctor's guide to the inflammatory process in the gastrointestinal tract

C. Hawkey, S. Pathmakanthan, Shri Pathmakanthan, 2000, Postgraduate medical journal.

Probiotics for maintenance of remission in Crohn's disease.

C. Hawkey, V. Rolfe, F. Bath-Hextall, 2006, The Cochrane database of systematic reviews.

Healing and prevention of NSAID-induced peptic ulcers.

C. Hawkey, 1994, Scandinavian journal of gastroenterology. Supplement.

A flow cytometric method to measure shape change of human neutrophils.

C. Hawkey, A. Galvin, R. Robins, 1995, Clinical science.

Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men.

J. Danesh, J. Atherton, C. Hawkey, 2000, Circulation.

Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia

R. de Caterina, J. McMurray, J. Hallas, 2014, BMJ Open.

Vacuolating Cytotoxin (vacA) Alleles of Helicobacter pylori Comprise Two Geographically Widespread Types, m1 and m2, and Have Evolved Through Limited Recombination

M. Blaser, P. Sharp, T. Cover, 1999, Current Microbiology.

Simple and Accurate PCR-Based System for Typing Vacuolating Cytotoxin Alleles of Helicobacter pylori

M. Blaser, T. Cover, C. Hawkey, 1999, Journal of Clinical Microbiology.

University of Southern Denmark Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib

J. McMurray, J. Hallas, D. Grobbee, 2017 .

Serum REG3alpha and C-Reactive Protein Levels in Crohn's Disease Patients Undergoing Immunoablation and Autologous Hemopoetic Stem Cell Transplantation in the ASTIC Trial

C. Hawkey, G. Rogler, E. Holler, 2015, Digestion.

Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis.

C. Hawkey, Y. Mahida, A. Hawthorne, 1991, British journal of clinical pharmacology.

Role of Eicosanoids in the Pathogenesis of Inflammatory Bowel Diseases

C. Hawkey, N. Boughton-Smith, B. Whittle, 1985 .

Gastric mucosal protection with selective inhibition of thromboxane synthesis.

C. Hawkey, R. Walt, J. G. Davies, 1987, Gut.

Ranitidine: differential effects on gastric bleeding and mucosal damage induced by aspirin

C. Hawkey, A. Hawthorne, Y. Mahida, 1992, Alimentary pharmacology & therapeutics.

Enhanced gastric mucosal bleeding with doses of aspirin used for prophylaxis and its reduction by ranitidine.

C. Hawkey, R. Walt, T. Daneshmend, 1989, British journal of clinical pharmacology.

Helicobacter pylori infection: expectations for future therapy

C. Hawkey, 2000 .

Journals should see original protocols for clinical trials

C. Hawkey, 2001, BMJ : British Medical Journal.

Nature and time‐course of piroxicam‐induced injury to human gastric mucosa

C. Hawkey, I. Fellows, C. J. Hawkey, 1989, Alimentary pharmacology & therapeutics.

Endoscopic evaluation of the gastro‐duodenal tolerance of short‐term analgesic treatment with 25 mg diclofenac‐K liquid capsules

C. Hawkey, J. Mannath, A. Norman, 2012, Alimentary pharmacology & therapeutics.

Fatal theophylline toxicity precipitated by in situ pulmonary artery thrombosis.

C. Hawkey, R. Davies, 1989, Postgraduate medical journal.

In vivo rectal inflammatory mediator changes with radiotherapy to the pelvis.

C. Hawkey, M. Sokal, A. Cole, 1993, Gut.

COX-2 chronology

C. Hawkey, 2005, Gut.

Safety of acid-suppressing drugs

C. Hawkey, P. Lundborg, R. Smallwood, 1995, Digestive Diseases and Sciences.

An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial.

S. Targan, M. Kamm, C. Hawkey, 2001, Gastroenterology.

The CINOD, AZD3582, exhibits an improved gastrointestinal safety profile compared with naproxen in healthy volunteers

C. Hawkey, U. Fagerholm, I. Bjarnason, 2003, InflammoPharmacology.

High prevalence of potentially virulent strains ofHelicobacter pylori in the general male British population

J. Danesh, J. Atherton, C. Hawkey, 2000, Gut.

interleukin 8 and leukotriene B 4 . movement in ulcerative colitis : the role of Mucosal factors inducing neutrophil

C. Hawkey, M. Balsitis, A. Cole, 2006 .

Therapeutic interventions in gastrointestinal disease based on an understanding of inflammatory mediators

C. Hawkey, A. Hawthorne, Y. Mahida, 2005, Agents and Actions.

Therapeutic interventions in gastrointestinal disease based on an understanding of inflammatory mediators

C. Hawkey, A. Hawthorne, Y. Mahida, 2005, Agents and Actions.

Mucosal factors inducing neutrophil movement in ulcerative colitis: the role of interleukin 8 and leukotriene B4.

C. Hawkey, M. Balsitis, A. Cole, 1996, Gut.

Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa

C. Hawkey, L. Jackson, Y. Mahida, 2000, Gut.

Non-steroid anti-inflammatory drug-associated upper gastrointestinal ulceration and complications : NSAIDs in the upper gastrointestinal tract

C. Hawkey, N. Hudson, 1993 .

Does “near patient” H. pylori testing in primary care reduce referral for endoscopy? Results from a randomised trial

C. Hawkey, A. Duggan, R. Logan, 1998 .

Quality of life in chronic NSAID users: a comparison of the effect of omeprazole and misoprostol.

I. Wiklund, C. Hawkey, G. Långström, 2001, Scandinavian journal of rheumatology.

High dose eicosapentaenoic acid ethyl ester: effects on lipids and neutrophil leukotriene production in normal volunteers.

C. Hawkey, A. Hawthorne, B. Filipowicz, 1990, British journal of clinical pharmacology.

Drug-induced gastrointestinal disorders

C. Hawkey, A. Norman, C. Sharratt, 2003, Medicine.

Clinical efficacy of the Toll-like receptor 9 agonist cobitolimod using patient-reported-outcomes defined clinical endpoints in patients with ulcerative colitis.

M. Neurath, C. Hawkey, R. Atreya, 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Nitric oxide donating compounds stimulate human colonic ion transport in vitro.

C. Hawkey, W. Stack, B. Filipowicz, 1996, Gut.

Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation

C. Hawkey, B. Scott, D. Jenkins, 2000, The Journal of pathology.

Autologous stem cell transplantation in refractory Crohn’s disease – low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study

R. Emsley, M. Parkes, J. Satsangi, 2019, BMC Gastroenterology.

Expression of cyclooxygenase 1 and 2 by human gastric endothelial cells

C. Hawkey, M. Hull, J. Thomson, 1999, Gut.

Clarification of the link between polyunsaturated fatty acids and Helicobacter pylori-associated duodenal ulcer disease: a dietary intervention study

R. Spiller, C. Hawkey, M. Balsitis, 1997, British Journal of Nutrition.

Development of biliary sludge in patients on intensive care unit: results of a prospective ultrasonographic study.

C. Hawkey, F. Murray, S. Stinchcombe, 1992, Gut.

Exploring the genetic architecture of inflammatory bowel disease

Loukas Moutsianas, Alison Simmons, Joshua Randall, 2016 .

Evidence that prednisolone is inhibitory to the cyclooxygenase activity of human rectal mucosa.

C. Hawkey, 1982 .

Effect of prednisolone on prostaglandin synthesis by rectal mucosa in ulcerative colitis: investigation by laminar flow bioassay and radioimmunoassay.

C. Hawkey, S. Truelove, 1981, Gut.

The need for prophylactic treatment to the central nervous system in patients with aggressive non-Hodgkin's lymphoma.

C. Hawkey, P. Toghill, 1983, Postgraduate medical journal.

Cyclooxygenase-2 inhibitors

C. Hawkey, P. Fortun, 2005, Current opinion in gastroenterology.

Life after Vioxx: the clinical implications.

C. Hawkey, P. Fortun, 2005, Hospital Medicine.

Lactobacillus plantarum 299: Beneficial in vitro immunomodulation in cells extracted from inflamed human colon

C. Hawkey, C. Li, S. Pathmakanthan, 2004, Journal of gastroenterology and hepatology.

Recruitment to a large scale randomised controlled clinical trial in primary care: the Helicobacter Eradication Aspirin Trial (HEAT)

D. Kendrick, C. Hawkey, A. Avery, 2022, Trials.

Effect of a test meal on the intragastric distribution of urea in the 13C-urea breath test for Helicobacter pylori.

R. Spiller, J. Atherton, C. Hawkey, 1995, Gut.

Possible low-dose-aspirin-induced gastropathy

C. Hawkey, A. Cole, N. Hudson, 1992, The Lancet.

Biosynthesis of lipoxygenase and cyclo-oxygenase products from [14C]-arachidonic acid by human colonic mucosa.

C. Hawkey, N. Boughton-Smith, B. Whittle, 1983, Gut.

Use of microbleeding and an ultrathin endoscope to assess gastric mucosal protection by famotidine.

C. Hawkey, P. Millns, T. Daneshmend, 1989, Gastroenterology.

Authors' reply: Nonselective nonsteroidal anti-inflammatory drugs and increased cardiovascular events: stress could be the explanation.

C. Hawkey, 2007 .

Colorectal leukotriene B4 synthesis in vitro in inflammatory bowel disease: inhibition by the selective 5-lipoxygenase inhibitor BWA4C.

C. Hawkey, N. Boughton-Smith, A. Hawthorne, 1992, Gut.

Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis

C. Hawkey, A. Kivitz, S. Nayiager, 2004, Alimentary pharmacology & therapeutics.

NSAID toxicity: where are we and how do we go forward?

C. Hawkey, 2002, The Journal of rheumatology.

Education and debate

C. Hawkey, 2022 .

special situations diagnosis and management of Crohn's disease: European evidence based consensus on the

A. Forbes, C. Hawkey, F. Baert, 2006 .

Healing with basic fibroblast growth factor is associated with reduced indomethacin induced relapse in a human model of gastric ulceration.

C. Hawkey, M. Hull, J. Brough, 1997, Gut.

Stem cell transplantation for Crohn's disease.

C. Hawkey, 2004, Best practice & research. Clinical haematology.

Roles of leukotriene B4, prostaglandin E2, and cyclic AMP in Campylobacter jejuni-induced intestinal fluid secretion

H. Goossens, C. Hawkey, P. Williams, 1993, Infection and immunity.

Morbidity and treatment in elderly patients surviving hospital admission with bleeding peptic ulcer.

C. Hawkey, R. Logan, S. Smith, 1995, Gut.

Disruption of colonic barrier function and induction of mediator release by strains of Campylobacter jejuni that invade epithelial cells.

R. Spiller, C. Hawkey, W. Stack, 2008, World journal of gastroenterology.

Highdoseeicosapentaenoic acid ethyl ester: effects onlipids and neutrophil leukotriene production innormal volunteers

C. Hawkey, A. Hawthorne, B. Filipowicz, 1990 .

Failure of ethamsylate to reduce aspirin-induced gastric mucosal bleeding in humans.

C. Hawkey, T. Daneshmend, N. Bhaskar, 1989, British journal of clinical pharmacology.

Non‐steroidal anti‐inflammatory drugs and the gastric mucosa: mechanisms of damage and protection

C. Hawkey, C. J. Hawkey, C. Hawkey, 1988, Alimentary pharmacology & therapeutics.

Modulation of human colonic arachidonic acid metabolism by sulfasalazine

C. Hawkey, N. Boughton-Smith, B. Whittle, 1985, Digestive Diseases and Sciences.

Enhanced gastric mucosal leukotriene B4 synthesis in patients taking non-steroidal anti-inflammatory drugs.

C. Hawkey, M. Balsitis, N. Hudson, 1993, Gut.

SULPHASALAZINE AND PROSTAGLANDIN SYNTHESIS

C. Hawkey, 1981, The Lancet.

Imbalance of prostacyclin and thromboxane synthesis in Crohn's disease.

C. Hawkey, D. Rachmilewitz, F. Karmeli, 1983, Gut.

Personality, smoking and inflammatory bowel disease.

C. Hawkey, P. Standen, R. Logan, 1996, European journal of gastroenterology & hepatology.

High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis.

C. Hawkey, Y. Mahida, A. Gallagher, 1991, Gut.

NEUROLOGICAL ILLNESS IN PATIENT WITH NO IMMUNOLOGICAL RESPONSE TO MUMPS

C. Hawkey, P. Toghill, D. Whillis, 1982, The Lancet.

Controversies in Management: Eradication largely prevents relapse

C. Hawkey, 1994 .

Scintigraphic assessment of the intragastric distribution and gastric emptying of an encapsulated drug: the effect of feeding and of a proton pump inhibitor

R. Spiller, J. Atherton, C. Hawkey, 1994, Alimentary pharmacology & therapeutics.

PROSTAGLANDINS FOR PEPTIC ULCER: A PROMISE UNFULFILLED

C. Hawkey, R. Walt, R. P. Walt, 1986, The Lancet.

Adult human colonic subepithelial myofibroblasts express extracellular matrix proteins and cyclooxygenase-1 and -2.

T. Gray, C. Hawkey, M. Göke, 1997, American journal of physiology. Gastrointestinal and liver physiology.

Plasma and tissue interleukin‐2 receptor levels in inflammatory bowel disease

C. Hawkey, Y. Mahida, L. Kurlak, 1990, Clinical and experimental immunology.

Effect of allopurinol, sulphasalazine, and vitamin C on aspirin induced gastroduodenal injury in human volunteers.

M. McAlindon, C. Hawkey, A. Muller, 1996, Gut.

Normal human colonic subepithelial myofibroblasts enhance epithelial migration (restitution) via TGF-beta3.

C. Hawkey, D. Podolsky, S. Makh, 1999, The American journal of physiology.

Adult human colonic subepithelial myofibroblasts express extracellular matrix proteins and cyclooxygenase-1 and -2.

T. Gray, C. Hawkey, M. Göke, 1997, The American journal of physiology.

Toxicity of Mycophenolate Mofetil in Patients with Inflammatory Bowel Disease

C. Hawkey, R. Logan, Y. Mahida, 2002, Inflammatory bowel diseases.

Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs.

C. Hawkey, M. Balsitis, F. Filipowicz, 1993, Gut.

Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders.

C. Hawkey, W. Stack, P. Richardson, 1998, Drugs.

Immunosuppressive Drugs in Inflammatory Bowel Disease

C. Hawkey, A. Hawthorne, 1989, Drugs.

Medical treatment of ulcerative colitis: scoring the advances.

C. Hawkey, A. Hawthorne, 1988, Gut.

5-Aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease.

C. Hawkey, Y. Mahida, A. Hawthorne, 1991, Gut.

Plasmaandtissue interleukin-2 receptor levels ininflammatory boweldisease

C. Hawkey, Y. Mahida, L. Kurlak, 1990 .

Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers.

C. Hawkey, R. Russell, F. Lee, 1999, Gastroenterology.

A Comparison of Omeprazole with Ranitidine for Ulcers Associated with Nonsteroidal Anti-inflammatory Drugs

C. Hawkey, Z. Tulassay, I. Rácz, 1999 .

Cyclooxygenase (COX)-1 and-2 in human gastric mucosa: Constitutive expression by parietal cells and induction of COX-2 in lamina propria cells proximal to ulcers

C. Hawkey, L. Jackson, Y. Mahida, 1998 .

Peptic ulcer bleeding in the elderly: relative roles ofHelicobacter pylori and non-steroidal anti-inflammatory drugs

C. Hawkey, D. Greenwood, H. Humphreys, 1997, Gut.

Intravenous omeprazole rapidly raises intragastric pH.

C. Hawkey, M. Langman, G. Kitchingman, 1985, Gut.

Eradication of Helicobacter pylori should be pivotal in managing peptic ulceration. Eradication largely prevents relapse.

C. Hawkey, 1994, BMJ.

High definition colonoscopy vs. standard video endoscopy for the detection of colonic polyps: a meta-analysis

C. Hawkey, K. Ragunath, J. Mannath, 2011, Endoscopy.

Proposed pathogenic mechanism for the diarrhea associated with human intestinal spirochetes.

C. Hawkey, F. Rodgers, C. Rodgers, 1986, American journal of clinical pathology.

Peptic ulcer bleeding in the elderly: relative roles ofHelicobacter pylori and non-steroidal anti-inflammatory drugs

C. Hawkey, D. Greenwood, H. Humphreys, 1997, Gut.

Comparison of effects of calcium carbasalate and aspirin on gastroduodenal mucosal damage in human volunteers.

C. Hawkey, J. Atherton, A. Cole, 1996, Gut.

Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points

C. Hawkey, A. Mcintyre, R. G. Long, 2001, Gut.

Characterization of Etoricoxib, a Novel, Selective COX‐2 Inhibitor

C. Hawkey, S. Waldman, L. DeTora, 2003, Journal of clinical pharmacology.

Inhibition of prostaglandin synthetase in human rectal mucosa.

C. Hawkey, M. Lo Casto, 1983, Gut.

Correction: Prophylactic antibiotics and caesarean section

C. Hawkey, 1990 .

Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy Multinational Study Group.

C. Hawkey, L. Laine, J. Bolognese, 2000, Arthritis and rheumatism.

Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors

C. Hawkey, M. Langman, 2003, Gut.

Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials

R. Hunt, N. Bhala, M. Hochberg, 2018, The lancet. Gastroenterology & hepatology.

Therapeutic approaches to the problem of biliary sludge and gallstone formation during total parenteral nutrition.

C. Hawkey, F. Murray, 1992, Clinical nutrition.

Evidence that adaptive cytoprotection in rats is not mediated by prostaglandins.

C. Hawkey, R. Walt, J. Davies, 1988, Gastroenterology.

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

S. Hill, C. Hawkey, D. Henry, 1996, BMJ.

Plasma exchange and immunosuppressive drug treatment in myasthenia gravis: no evidence for synergy.

C. Hawkey, A. Vincent, J. Newsom-Davis, 1981, Journal of neurology, neurosurgery, and psychiatry.

Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease.

M. Tremelling, M. Parkes, C. Lees, 2016, Journal of Crohn's & colitis.

Omeprazole Compared with Misoprostol for Ulcers Associated with Nonsteroidal Antiinflammatory Drugs

A. Barkun, C. Hawkey, L. Szczepański, 1998 .

Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.

C. Hawkey, R. Russell, R. Sturrock, 1996, The New England journal of medicine.

Textbook of clinical gastroenterology and hepatology

C. Hawkey, 2012 .

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.

C. Hawkey, Z. Tulassay, I. Rácz, 1998, The New England journal of medicine.

Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation

C. Hawkey, M. Labopin, J. Snowden, 2011, Bone Marrow Transplantation.

COX-2 Selective Nonsteroidal Anti-Inflammatory Drugs

C. Hawkey, L. Jackson, 2000, Drugs.

Consuming broccoli does not induce genes associated with xenobiotic metabolism and cell cycle control in human gastric mucosa.

Moira A. Taylor, C. Hawkey, D. Barrett, 2007, The Journal of nutrition.

Nonsteroidal anti-inflammatory drug gastropathy.

C. Hawkey, C J Hawkey, 2000, Gastroenterology.

Effect of indomethacin and misoprostol on fasted gallbladder volume and meal-induced gallbladder contractility in humans

C. Hawkey, F. Murray, S. Stinchcombe, 1992, Digestive diseases and sciences.

A monoclonal antibody reactive with human hepatocytes.

R. W. Baldwin, C. Hawkey, P. Smith, 2008, Liver.

Patterns of reactivity of the monoclonal antibody 791T/36 with different tumour metastases in the liver.

R. W. Baldwin, C. Hawkey, P. Smith, 1986, British Journal of Cancer.

Patterns ofreactivity ofthemonoclonal antibody 791T/36 withdifferent tumourmetastases intheliver

R. W. Baldwin, C. Hawkey, P. Smith, 1986 .

INTERLEUKIN‐8 AND INDUCIBLE NITRIC OXIDE SYNTHASE mRNA LEVELS IN INFLAMMATORY BOWEL DISEASE AT FIRST PRESENTATION

C. Hawkey, B. Scott, G. Vautier, 1997, The Journal of pathology.

An irritable bowel syndrome-specific symptom questionnaire: development and validation.

I. Wiklund, S. Fullerton, C. Hawkey, 2003, Scandinavian journal of gastroenterology.

Basic fibroblast growth factor treatment for non-steroidal anti-inflammatory drug associated gastric ulceration.

C. Hawkey, M. Hull, D. Cullen, 1995, Gut.

A Novel Composite Endpoint to Evaluate the Gastrointestinal Effects of NSAID Through the Entire GI Tract: Introducing CSULGIE

C. Hawkey, 2010, The Journal of Rheumatology.

NSAID Through the Entire GI Tract : Introducing CSULGIE A Novel Composite Endpoint to Evaluate the Gastrointestinal Effects

C. Hawkey, 2009 .

Decreased salivary epidermal growth factor in rheumatoid disease

C. Hawkey, P. Jones, 1990, BMJ.

Depression of salivary epidermal growth factor by smoking.

C. Hawkey, P. Jones, N. Hudson, 1992, BMJ.

Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial.

J. Satsangi, J. Gribben, S. Vermeire, 2015, JAMA.

A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis

Beryl B. Cummings, Judy H. Cho, M. Rivas, 2015, Nature Communications.

Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease

J. Danesh, M. Daly, J. Stelling, 2020, Nature Communications.

Materials for : Host-microbe interactions shape genetic risk for inflammatory bowel disease

Judy H. Cho, C. Gieger, M. Daly, 2012 .

New treatments in inflammatory bowel disease.

C. Hawkey, A. Cole, 1992, British journal of hospital medicine.

Potential role for peroxisome proliferator activated receptor (PPAR) in preventing colon cancer

W. Wahli, C. Hawkey, T. Morris, 2003, Gut.

Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplasia in Barrett’s esophagus: a meta-analysis

C. Hawkey, K. Ragunath, J. Mannath, 2010, Endoscopy.

Narrow-band imaging with magnification in Barrett’s esophagus: validation of a simplified grading system of mucosal morphology patterns against histology

K. Garsed, K. Yao, C. Hawkey, 2008, Endoscopy.

Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy.

C. Hawkey, A. Hawthorne, 1989, Drugs.

Nocardia asteroides lung abscess in acute ulcerative colitis treated with cyclosporine.

C. Hawkey, W. Stack, R. Logan, 2001 .

Human SNP Links Differential Outcomes in Inflammatory and Infectious Disease to a FOXO3-Regulated Pathway

Tariq Ahmad, Alison Simmons, David C. Wilson, 2013, Cell.

The Prader-Willi syndrome with a 15/15 translocation. Case report and review of the literature.

C. Hawkey, A. Smithies, 1976, Journal of medical genetics.

Comparison of High Definition with Standard White Light Endoscopy for Detection of Dysplastic Lesions During Surveillance Colonoscopy in Patients with Colonic Inflammatory Bowel Disease

C. Hawkey, K. Ragunath, J. Mannath, 2011, Inflammatory bowel diseases.

Meta‐analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease

C. Hawkey, K. Ragunath, J. Mannath, 2011, Alimentary pharmacology & therapeutics.

The nonsteroidal anti-inflammatory drugs controversy.

C. Hawkey, G. Garas, N. Yeomans, 2000, Gastroenterology clinics of North America.

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

X. Y. Zhang, T. Schnitzer, A. Laupacis, 2013, BDJ.

The laboratory control of thrombolytic therapy

C. Hawkey, M. Howell, 1964, Journal of clinical pathology.

Transcriptome analysis of human colon Caco-2 cells exposed to sulforaphane.

C. Hawkey, R. Mithen, M. Traka, 2005, The Journal of nutrition.

Audit of outcome of long-term enteral nutrition by percutaneous endoscopic gastrostomy

C. Hawkey, S. Allison, M. Hull, 1993, The Lancet.

Update in the Pharmacological Management of Peptic Ulcer Haemorrhage

C. Hawkey, N. Selby, A. Kubba, 2001, Scandinavian journal of gastroenterology.

Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial.

C. Hawkey, R. Logan, M. Langman, 1992, BMJ.

Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine.

I. Moules, C. Hawkey, K. Wormsley, 1993, Gut.

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial

T. Schnitzer, M. Hochberg, M. Farkouh, 2004, The Lancet.

Familial varices of the colon occurring without evidence of portal hypertension.

C. Hawkey, P. Toghill, S. Amar, 1985, The British journal of radiology.

Arterial Occlusion Treated with Streptokinase

C. Hawkey, R. Rees, M. Clark, 1965 .

A Method for Investigating the Effects of Drugs on the Prostaglandin Synthetase of Single Rectal Biopsies

D. Jewell, C. Hawkey, 1981 .

Nonsteroidal antiinflammatory drugs and the small intestine

C. Hawkey, P. Fortun, 2007, Current opinion in gastroenterology.

ARTERIAL OCCLUSION TREATED WITH STREPTOKINASE. A REPORT OF TWO CASES.

C. Hawkey, R. Rees, M. Clark, 1965, Postgraduate medical journal.

The Impact of Different DNA Extraction Kits and Laboratories upon the Assessment of Human Gut Microbiota Composition by 16S rRNA Gene Sequencing

H. Drummond, C. Lees, J. Satsangi, 2014, PloS one.

TGF-α reduces bradykinin-stimulated ion transport and prostaglandin release in human colonic epithelial cells.

C. Hawkey, W. Stack, J. Beltinger, 1999, American journal of physiology. Cell physiology.

Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells.

J. Morrow, R. Coffey, C. Hawkey, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Gastroduodenal toxicity of low-dose acetylsalicylic acid: a comparison with non-steroidal anti-inflammatory drugs

C. Hawkey, N. Yeomans, J. Næsdal, 2009, Current medical research and opinion.

Brief review Gastroduodenal toxicity of low-dose acetylsalicylic acid: a comparison with non-steroidal anti-inflammatory drugs

C. Hawkey, N. Yeomans, J. Naesdal, 2009 .

Effect in man of aspirin, standard indomethacin, and sustained release indomethacin preparations on gastric bleeding.

C. Hawkey, P. Prichard, J. Willars, 1988, British journal of clinical pharmacology.

Normal human colonic subepithelial myofibroblasts enhance epithelial migration (restitution) via TGF-β3.

C. Hawkey, D. Podolsky, S. Makh, 1999, American journal of physiology. Gastrointestinal and liver physiology.

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial

T. Schnitzer, M. Hochberg, C. Hawkey, 2004, The Lancet.

Ratio of visceral to subcutaneous fat area is a biomarker of complicated Crohn's disease.

C. Hawkey, R. Dhingsa, V. Subramanian, 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study

C. Hawkey, L. Laine, H. Badsha, 2003, Gut.

STOMACH Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib , naproxen , or placebo : a multicentre , randomised , double blind study

C. Hawkey, L. Laine, H. Quan, 2003 .

Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis

M. Neurath, C. Hawkey, R. Atreya, 2016, Journal of Crohn's & colitis.

Hematopoietic Stem Cell Transplantation in Crohn's Disease: State-of-the-Art Treatment

C. Hawkey, 2017, Digestive Diseases.

Rdp58 Is a Novel and Potentially Effective Oral Therapy for Ulcerative Colitis

C. Hawkey, B. Warren, S. Travis, 2005, Inflammatory bowel diseases.

Beliefs about personal control and self-management in 30-40 year olds living with Inflammatory Bowel Disease: a qualitative study.

C. Hawkey, J. Collier, Joanne Cooper, 2010, International journal of nursing studies.

A national training programme for gastroenterology and hepatology.

C. Hawkey, W. Burnham, J. Bennett, 1996, Gut.

Late mortality in elderly patients surviving acute peptic ulcer bleeding.

C. Hawkey, R. Logan, M. Langman, 1995, Gut.

Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial

J. Cuzick, C. Hawkey, I. Roberts, 2019, Trials.

Helicobacter pylori, NSAIDs and cognitive dissonance

C. Hawkey, C. J. Hawkey, 1999, Alimentary pharmacology & therapeutics.

Are NSAIDs and Helicobacter pylori separate risk factors

C. Hawkey, 1996 .

SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking

C. Hawkey, J. Snowden, A. Velardi, 2014, Bone Marrow Transplantation.

Monoclonal antigranulocyte antibody imaging in inflammatory bowel disease: a preliminary report.

C. Hawkey, A. Perkins, M. Wastie, 1992, Nuclear medicine communications.

Effect of reactive pharmacy intervention on quality of hospital prescribing.

C. Hawkey, S. Hodgson, T. Daneshmend, 1990, BMJ.

Autologous Haematopoietic Stem Cell Transplantation for Crohn’s Disease: A Retrospective Survey of Long-term Outcomes From the European Society for Blood and Marrow Transplantation

J. Satsangi, S. Vermeire, C. Hawkey, 2018, Journal of Crohn's & colitis.

OP021 Autologous haematopoietic stem cell transplantation for Crohn’s disease: a retrospective study from the European Society for Blood & Marrow Transplantation (EBMT) Autoimmune Diseases Working Party

J. Satsangi, S. Vermeire, C. Hawkey, 2018 .

Stem Cell Transplantation for Refractory Crohn Disease--Reply.

J. Gribben, C. Hawkey, J. Lindsay, 2016, Journal of the American Medical Association (JAMA).

Colitis associated with non-steroidal anti-inflammatory drugs.

C. Hawkey, M. Langman, R. Walt, 1984, British medical journal.

Stem Cells as Treatment in Inflammatory Bowel Disease

C. Hawkey, 2013, Digestive Diseases.

Less small-bowel injury with lumiracoxib compared with naproxen plus omeprazole.

M. McAlindon, C. Hawkey, M. Keuchel, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Cell adhesion molecule expression by colonic mucosa in ulcerative colitis

C. Hawkey, M. Balsitis, Y. Mahida, 1994 .

Synthesis of prostaglandin E2, thromboxane B2 and prostaglandin catabolism in gastritis and gastric ulcer.

C. Hawkey, 1986, Gut.

transepithelial resistance and secretory response Human colonic subepithelial myofibroblasts modulate

C. Hawkey, W. Stack, S. Makh, 2016 .

Human colonic subepithelial myofibroblasts modulate transepithelial resistance and secretory response.

C. Hawkey, W. Stack, S. Makh, 1999, The American journal of physiology.

Effect of sucralfate on aspirin induced mucosal injury and impaired haemostasis in humans.

C. Hawkey, A. Cole, N. Hudson, 1997, Gut.

Future treatments for arthritis: new NSAIDs, NO NSAIDs, or no NSAIDs?

C. Hawkey, 1995, Gastroenterology.

A thromboxane synthetase inhibitor in Raynaud's phenomenon.

C. Hawkey, E. Jones, 1983, Prostaglandins, leukotrienes, and medicine.

White light endoscopy, narrow band imaging and chromoendoscopy with magnification in diagnosing colorectal neoplasia.

Krish Ragunath, Rajvinder Singh, C. Hawkey, 2009, World journal of gastrointestinal endoscopy.

MISOPROSTOL, SMOKING, AND DUODENAL ULCER HEALING RATES

C. Hawkey, R. Walt, 1987, The Lancet.

Comparison of high-resolution magnification narrow-band imaging and white-light endoscopy in the prediction of histology in Barrett's oesophagus

Krish Ragunath, Venkataraman Subramaniam, Rajvinder Singh, 2009, Scandinavian journal of gastroenterology.

Optical Microangiography: High-Definition Magnification Colonoscopy with Narrow Band Imaging (NBI) for Visualizing Mucosal Capillaries and Red Blood Cells in the Large Intestine.

K. Yao, C. Hawkey, K. Ragunath, 2008, Gut and liver.

Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study

C. Hawkey, A. Avery, I. Ford, 2016, BMJ Open.

Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT)

J. McMurray, J. Hallas, D. Grobbee, 2016, European heart journal.

Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial

A. Doney, C. Hawkey, A. Avery, 2022, The Lancet.

Separation of the impairment of haemostasis by aspirin from mucosal injury in the human stomach.

C. Hawkey, A. Hawthorne, Y. Mahida, 1991, Clinical science.

Prevention of Ulcers by Esomeprazole in At-Risk Patients Using Non-Selective NSAIDs and COX-2 Inhibitors

F. Chan, C. Hawkey, N. Talley, 2006, The American Journal of Gastroenterology.

Pharmacology and gastrointestinal safety of lumiracoxib, a novel cyclooxygenase-2 selective inhibitor: An integrated study.

C. Hawkey, C. Rordorf, J. Branson, 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Questions regarding future research on aspirin and the gastrointestinal tract.

C. Hawkey, B. Hirschowitz, 2001, The American journal of medicine.

Ranitidine, aspirin, food, and the stomach.

C. Hawkey, A. Hawthorne, Y. Mahida, 1992, BMJ.

Nonsteroidal Anti-inflammatory Drug Use Is a Significant Cause of Peptic Ulcer Disease in a Tertiary Hospital in Singapore: A Prospective Study

C. Hawkey, K. Ho, T. Ong, 2006, Journal of clinical gastroenterology.

Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration.

C. Hawkey, R. Russell, A. Taha, 1997, Gastroenterology.

Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT)

C. Hawkey, I. Ford, T. MacDonald, 2013, BMJ Open.

Personal review: Helicobacter pylori, NSAIDs and cognitive dissonance.

C. Hawkey, 1999, Alimentary pharmacology & therapeutics.

Indigestion and non-steroidal anti-inflammatory drugs

C. Hawkey, J. Seager, 2001, BMJ : British Medical Journal.

TGF-alpha reduces bradykinin-stimulated ion transport and prostaglandin release in human colonic epithelial cells.

C. Hawkey, W. Stack, J. Beltinger, 1999, The American journal of physiology.

Abolition by omeprazole of aspirin induced gastric mucosal injury in man.

C. Hawkey, T. Daneshmend, C. J. Hawkey, 1990, Gut.

Non-steroidal anti-inflammatory drugs in patients with peptic ulcer disease: rarely justified in terms of cost or patient benefit.

C. Hawkey, C. J. Hawkey, 1989, BMJ.

Omeprazole and bleeding peptic ulcer, or "how case-control studies can tell you what you suspected all along".

C. Hawkey, 1999, Epidemiology.

Safer NSAID strategies: consensus or contentious?

C. Hawkey, 2008, Rheumatology.

Elevated Rectal Leukotriene B4, Thromboxane B2 and Prostaglandin E2 Levels in Patients Having Pelvic Radiotherapy

C. Hawkey, M. Sokal, L. Kurlak, 1993 .

THE DISCOVERY OF HELICOBACTER PYLORI

C. Hawkey, 2011 .

High-resolution magnification endoscopy can reliably identify normal gastric mucosa, Helicobacter pylori-associated gastritis, and gastric atrophy

K. Yao, C. Hawkey, K. Ragunath, 2007, Endoscopy.

[Plasmapheresis for myasthenia gravis].

C. Hawkey, A. Vincent, C. Ward, 1978, The New England journal of medicine.

Isolated crypts form spheres prior to full intestinal differentiation when grown as xenografts: an in vivo model for the study of intestinal differentiation and crypt neogenesis, and for the abnormal crypt architecture of juvenile polyposis coli

C. Hawkey, N. Wright, Chung-Yin Lee, 2005, The Journal of pathology.

Time-trends in gastroprotection with NSAIDs

T. Schnitzer, S. Gabriel, J. Lei, 2010 .

Utility of Kudo Pit Pattern for Distinguishing Adenomatous from Non Adenomatous Colonic Lesions In Vivo: Meta-Analysis of Different Endoscopic Techniques

C. Hawkey, K. Ragunath, J. Mannath, 2009 .

The role of stem cell transplantation in inflammatory bowel disease

C. Hawkey, P. Fortun, C J Hawkey, 2008, Autoimmunity.

Improvements with Esomeprazole in Patients with Upper Gastrointestinal Symptoms Taking Non-Steroidal Antiinflammatory Drugs, Including Selective COX-2 Inhibitors

C. Hawkey, N. Talley, G. Långström, 2005, The American Journal of Gastroenterology.

The gastroenterologist's caseload: contribution of the rheumatologist.

C. Hawkey, 1997, Seminars in arthritis and rheumatism.

Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention.

C. Hawkey, Á. Lanas, Z. Tulassay, 1998, Lancet.

Helicobacter pylori and nonsteroidal anti-inflammatory drugs: a three-way debate.

F. Chan, C. Hawkey, Á. Lanas, 2001, The American journal of medicine.

Rebeprazole vs omeprazole in 7-day, triple-therapy H pylori eradication regimens for peptic ulcer

B. Thjódleifsson, C. Hawkey, M. Ravic, 2001 .

Esomeprazole provides effective control of NSAID-associated upper GI symptoms in patients continuing to take NSAIDs

C. Hawkey, G. Långström, J. Scheiman, 2003 .

Expression and functions of purinergic receptor P2X7 in colonic macrophages and T lymphocytes from normal and inflammatory bowel disease mucosa

T. Gray, C. Hawkey, C. Li, 2001 .

Nitric oxide synthase activity in ulcerative colitis and Crohn's disease

C. Hawkey, M. Balsitis, S. Moncada, 1993, The Lancet.

Influence of H. pylori and other potential risk factors on clinical gi events in a double-blind outcome study of rofecoxib VS. Naproxen

C. Bombardier, C. Hawkey, L. Laine, 2000 .

Esomeprazole maintains control of upper GI symptoms in patients on NSAID therapy

C. Hawkey, N. Talley, J. Sung, 2003, American Journal of Gastroenterology.

Specific mediator-directed therapy for gastrointestinal diseases.

C. Hawkey, W. Stack, 1997, European journal of gastroenterology & hepatology.

Living with Crohn’s disease: an exploratory cross-sectional qualitative study into decision-making and expectations in relation to autologous haematopoietic stem cell treatment (the DECIDES study)

C. Hawkey, J. Lindsay, Joanne Cooper, 2017, BMJ Open.

Nitric oxide donating flurbiprofen (HCT 1026) causes less endoscopic damage in healthy volunteers than flurbiprofen

C. Hawkey, P. Soldato, N. Garlick, 1998 .

Presence of the purinergic receptor P2X7 in colonic macrophages and T cells from normal and IBD mucosa

C. Hawkey, C. Li, M. Lawson, 2000 .

Gastrointestinal safety of selective COX-2 inhibitors.

C. Hawkey, M. Skelly, 2002, Current pharmaceutical design.

The Prader-Willi syndrome with a 15/15 translocation. Case report and review of the literature.

C. Hawkey, A. Smithies, 1976, Journal of medical genetics.

Efficacy of New Playback Functions at Reducing Small-Bowel Wireless Capsule Endoscopy Reading Times

C. Hawkey, K. Ragunath, J. Mannath, 2012, Digestive Diseases and Sciences.

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

A. Barkun, C. Hawkey, L. Szczepański, 1999, The New England journal of medicine.

Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis.

C. Hawkey, J. Dequeker, C. Alegre, 1998, British journal of rheumatology.

Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.

C. Hawkey, J. Dequeker, C. Alegre, 1998, British journal of rheumatology.

Primary gastroduodenal prophylaxis with omeprazole for non‐steroidal anti‐inflammatory drug users

Thomson, C. Hawkey, Hawkey, 1998, Alimentary pharmacology & therapeutics.

Irritable bowel syndrome clinical trial design: future needs.

C. Hawkey, C. Hawkey, 1999, The American journal of medicine.

Prophylaxis of aspirin‐induced gastric mucosal bleeding with ranitidine

C. Hawkey, K. Somerville, C. J. Hawkey, 1988, Alimentary pharmacology & therapeutics.

Does concurrent prescription of selective serotonin reuptake inhibitors and non‐steroidal anti‐inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?

R. Hubbard, L. Smeeth, C. Hawkey, 2005, Alimentary pharmacology & therapeutics.

Failure of Helicobacter pylori eradication to influence site-specific relapse in high risk NSAID users: Results of a large six month double blind randomised controlled clinical trial

C. Hawkey, Á. Lanas, C. Rensburg, 1998 .

Assessing bleeds clinically: what's the score?

C. Hawkey, V. Subramanian, 2009, The Lancet.

Doubt and certainty about nonsteroidal anti-inflammatory drugs in the year 2000: a multidisciplinary expert statement.

C. Hawkey, Á. Lanas, C. Hawkey, 2001, The American journal of medicine.

Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment?

C. Hawkey, D. Rampton, C. Hawkey, 1985, Gastroenterology.

European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations

C. O'Morain, D. Hommes, C. Hawkey, 2006, Gut.

COX-1 and COX-2 inhibitors.

C. Hawkey, C. Hawkey, C J Hawkey, 2001, Best practice & research. Clinical gastroenterology.

A trial of zileuton versus mesalazine or placebo in the maintenance of remission of ulcerative colitis. The European Zileuton Study Group For Ulcerative Colitis.

L. Dubé, C. Hawkey, C. Hawkey, 1997, Gastroenterology.

Gastrointestinal effects of COX-2 inhibitors.

C. Hawkey, L. Jackson, C. Hawkey, 1999, Expert opinion on investigational drugs.

Non-steroidal anti-inflammatory drug gastropathy: causes and treatment.

C. Hawkey, C. Hawkey, 1996, Scandinavian journal of gastroenterology. Supplement.

The effect of naproxen on genes associated with DNA damage and repair in the stomach of healthy volunteers by microarray analysis

C. Hawkey, N. Shankley, M. James, 2003 .

Acetic acid‐enhanced magnification endoscopy in the diagnosis of specialized intestinal metaplasia, dysplasia and early cancer in Barrett's oesophagus

C. Hawkey, M. James, K. Ragunath, 2006, Alimentary pharmacology & therapeutics.

Randomised controlled trial of CDP571 antibody to tumour necrosis factor-α in Crohn's disease

M. Kamm, C. Hawkey, A. Forbes, 1997, The Lancet.

Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials

I. Wiklund, C. Hawkey, E. Mayer, 2001, Alimentary pharmacology & therapeutics.

Predictors of gastroduodenal erosions in patients taking low‐dose aspirin

C. Hawkey, Á. Lanas, N. Talley, 2010, Alimentary pharmacology & therapeutics.

INTRAVASCULAR HÆMOLYSIS AND COAGULATION

C. Hawkey, A. Blofield, 1967 .

What consideration should be given to Helicobacter pylori in treating nonsteroidal anti-inflammatory drug ulcers?

C. Hawkey, 2000, European Journal of Gastroenterology and Hepathology.

Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs

C. Hawkey, G. Långström, N. Yeomans, 2002, Gut.

Projections of alcohol-related deaths in England and Wales—tragic toll or potential prize?

C. Hawkey, N. Sheron, I. Gilmore, 2012, The Lancet.

Fibered Confocal Endomicroscopy: A Feasibility Study to Enhance Routine Endoscopy

C. Hawkey, Rajvinder Singh, K. Ragunath, 2007 .

Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention.

C. Hawkey, Á. Lanas, Z. Tulassay, 1998, Lancet.

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

Lise, HOMAS, T. Schnitzer, 2000, The New England journal of medicine.

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial

T. Schnitzer, M. Hochberg, C. Hawkey, 2004, The Lancet.

Management of gastroduodenal ulcers caused by non-steroidal anti-inflammatory drugs.

C. Hawkey, C. Hawkey, 2000, Bailliere's best practice & research. Clinical gastroenterology.

Projections of alcohol-related deaths in England and Wales—tragic toll or potential prize?

C. Hawkey, N. Sheron, I. Gilmore, 2012, The Lancet.

Randomised trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib

J. McMurray, J. Hallas, D. Grobbee, 2016 .

Lansoprazole versus ranitidine for the treatment of reflux oesophagitis

I. Moules, C. Hawkey, K. Wormsley, 1995, Alimentary pharmacology & therapeutics.

Non-steroid anti-inflammatory drug-associated upper gastrointestinal ulceration and complications : NSAIDs in the upper gastrointestinal tract

C. Hawkey, N. Hudson, 1993 .

Exploring the genetic architecture of inflammatory bowel disease by whole genome sequencing identifies association at ADCY7

Shane A. McCarthy, J. Barrett, M. Tremelling, 2016, Nature Genetics.

Evidence that the COX-2 specific inhibitor rofecoxib at 50 mg spares gastric mucosal prostaglandin synthesis in human

C. Hawkey, N. Calder, K. Gottesdiener, 2000 .

Education and debate

C. Hawkey, 2022 .

COX-1 expression in human gastric mucosa infected with Helicobacter pylori: Constitutive or induced?

C. Hawkey, L. Jackson, Y. Mahida, 1998 .